Search results
Results from the WOW.Com Content Network
An animation illustrating the exterior/interior compositions of a tablet of Concerta, a PSOP OROS design. In the early 1990s, an ALZA-funded research program began to develop a new dosage form of methylphenidate for the treatment of children with attention deficit hyperactivity disorder (ADHD). [14]
Valproate is known to cause serious abnormalities or birth defects in the unborn child if taken during pregnancy, [7] [8] and is contra-indicated for women of childbearing age unless the drug is essential to their medical condition and the person is also prescribed a contraceptive.
An enteric coating is a polymer barrier applied to oral medication that prevents its dissolution or disintegration in the gastric environment. [1] This helps by either protecting drugs from the acidity of the stomach, the stomach from the detrimental effects of the drug, or to release the drug after the stomach (usually in the upper tract of the intestine). [2]
Tablets with special coatings (for example, enteric coatings or controlled-release coatings) should not be broken before use, as this exposes the tablet core to the digestive juices, circumventing the intended delayed-release effect.
Guanfacine does not appear to be effective for improving sleep in children with ADHD and behavioral insomnia. [31] Instead, guanfacine worsened certain sleep parameters, for instance total sleep time, in one clinical trial. [31] [32] Guanfacine has been investigated for treatment of withdrawal for opioids, ethanol, and nicotine. [67]
For premium support please call: 800-290-4726 more ways to reach us
Enteric coated tablets are designed to dissolve in the intestine, not the stomach, because the drug present in the tablet causes irritation in the stomach. Administering medication rectally. The rectal route is an effective route of administration for many medications, especially those used at the end of life.
AOL Mail welcomes Verizon customers to our safe and delightful email experience!